000 | 02024 a2200553 4500 | ||
---|---|---|---|
005 | 20250515004318.0 | ||
264 | 0 | _c20051209 | |
008 | 200512s 0 0 eng d | ||
022 | _a0732-183X | ||
024 | 7 |
_a10.1200/JCO.2004.01.0033 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPui, Ching-Hon | |
245 | 0 | 0 |
_aRisk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2005 |
||
300 |
_a7936-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aCranial Irradiation |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xmortality |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTeniposide _xadministration & dosage |
700 | 1 | _aPei, Deqing | |
700 | 1 | _aSandlund, John T | |
700 | 1 | _aCampana, Dario | |
700 | 1 | _aRibeiro, Raul C | |
700 | 1 | _aRazzouk, Bassem I | |
700 | 1 | _aRubnitz, Jeffrey E | |
700 | 1 | _aHoward, Scott C | |
700 | 1 | _aHijiya, Nobuko | |
700 | 1 | _aJeha, Sima | |
700 | 1 | _aCheng, Cheng | |
700 | 1 | _aDowning, James R | |
700 | 1 | _aEvans, William E | |
700 | 1 | _aRelling, Mary V | |
700 | 1 | _aHudson, Melissa | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 23 _gno. 31 _gp. 7936-41 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2004.01.0033 _zAvailable from publisher's website |
999 |
_c15884966 _d15884966 |